Twinrix 58160-0815 hepaititis AB vaccine
Ended Awarded Last action
- Contract number
- W912LM22F0030
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Minnesota National Guard
Army National Guard, Department of Defense
- Obligated
- $72,172
Award facts
- Opportunity
-
- W912LM22Q0028 Solicitation number
- Contract value 100% obligated
- $72,171.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Little Falls, MN 56345, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Minnesota National Guard, a defense agency, to Glaxosmithkline, LLC for the delivery of TWINRIX 58160-0815 hepatitis AB vaccine. The $72,171.90 fixed-price delivery order was placed against Glaxosmithkline's existing GSA Pharmaceutical and Drugs schedule contract and has a completion date of June 1, 2022. The contract does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medications to various U.S. government agencies including the Departments of Defense, Veterans Affairs, and Health and Human Services. The company has experience supporting federal disease prevention, immunization, and drug stockpiling efforts through both contract and grant awards.
Quick answers
Who was awarded contract W912LM22F0030?
W912LM22F0030 was awarded to Glaxosmithkline, LLC by Minnesota National Guard (Army National Guard) on May 9, 2022.
How much is contract W912LM22F0030 worth?
The government has obligated $72,172 on W912LM22F0030.
Is contract W912LM22F0030 an order under another contract?
Yes. W912LM22F0030 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract W912LM22F0030 competed?
The extent of competition for W912LM22F0030 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award